Tag:
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- HTA in Medtech - Free SymposiumSaturday, June 2, 2012 — ISPOR Washington
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
Press Releases
- Sue Siegel to Lead Healthymagination
- CDC Announces First Ever National Hepatitis Testing Day and Proposes that All Baby Boomers Be Tested Once for Hepatitis C
- SLA Pharma AG Announces Clinically and Statistically Significant Phase 2 Results on Opioid Induced Constipation
- GenVec Appoints Cynthia Collins as President and CEO
- Achillion Announces Additional Proof-of-Concept Data With ACH-2684 for the Treatment of Hepatitis C
- More Press Releases
